Research map: Thirty‐day dapagliflozin therapy improves the nanomechanical properties of red blood cells in patients with type 1 diabetes

Back to the article

Papers in this map

  1. Dapagliflozin in Patients with Chronic Kidney Disease · Hiddo J.L. Heerspink · 2020 · 5532 citations · Cited by this paper
  2. Activation of sigma non‐opioid intracellular receptor 1 (S1R) receptor inhibits plexin domain containing 2 (Plxdc2) driven microglial inflammation to ameliorate depressive‐like behaviours in mice · 2026 · Related
  3. Empagliflozin in Patients with Chronic Kidney Disease · The EMPA-KIDNEY Collaborative Group · 2022 · 2647 citations · Cited by this paper
  4. Acute anaphylactic and multiorgan inflammatory effects of Comirnaty in pigs: evidence of spike protein mRNA transfection and paralleling inflammatory cytokine upregulation · 2026 · Related
  5. Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) · Melanie J. Davies · 2022 · 2106 citations · Cited by this paper
  6. A novel quinoline and manganese‐based carbon monoxide‐releasing molecule for intravesical therapy of bladder cancer · 2026 · Related
  7. Endothelial Nitric Oxide Synthase in Vascular Disease · Ulrich Förstermann · 2006 · 1943 citations · Cited by this paper
  8. Serotonin engages divergent 5‐HT receptor pathways for cell type‐resolved modulation of prefrontal layer 5 microcircuits · 2026 · Related
  9. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes · Nikolaus Marx · 2023 · 1602 citations · Cited by this paper
  10. Decoding functional specialization in G protein‐coupled receptors (GPCRs) through evolution‐guided residue profiling · 2026 · Related
  11. Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus · Hiddo J.L. Heerspink · 2016 · 1379 citations · Cited by this paper
  12. Arrhythmias associated with immune checkpoint inhibitor therapy—A clinical perspective · 2026 · Related
  13. Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials · Colin Baigent · 2022 · 1023 citations · Cited by this paper
  14. Targeting sphingosine‐1‐phosphate receptor‐2 attenuates spinal cord injury by preventing neuronal ferroptosis · 2026 · Related
  15. Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors · Gary D. Lopaschuk · 2020 · 908 citations · Cited by this paper
  16. Virtual cell construction for artificial intelligence‐driven drug discovery · 2026 · Related
  17. Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition · Anne L. Peters · 2015 · 849 citations · Cited by this paper
  18. A covalent peptide engager approach to equip immunotherapeutic monoclonal and pan IgG serum antibodies with new tumour‐targeting function · 2026 · Related
  19. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study · Araz Rawshani · 2018 · 816 citations · Cited by this paper
  20. Paecilomyces cicadae ‐fermented Radix astragali modulates short‐chain fatty acids metabolism in the intestine through gut microbiota and ameliorates hyperuricaemia · 2026 · Related
  21. Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors · Thomas A. Zelniker · 2020 · 570 citations · Cited by this paper
  22. Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications · Alfredo Caturano · 2023 · 559 citations · Cited by this paper
  23. Effect of Empagliflozin on Erythropoietin Levels, Iron Stores, and Red Blood Cell Morphology in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease · C. David Mazer · 2019 · 370 citations · Cited by this paper
  24. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. · Jean‐Luc Wautier · 1994 · 355 citations · Cited by this paper
  25. Temporal patterns in overweight and obesity in Type 1 diabetes · Baqiyyah N. Conway · 2010 · 330 citations · Cited by this paper
  26. Effects of nitric oxide on red blood cell deformability · Melek Bor-Küçükatay · 2003 · 308 citations · Cited by this paper
  27. Stiffness of normal and pathological erythrocytes studied by means of atomic force microscopy · Ida Dulińska · 2006 · 307 citations · Cited by this paper
  28. Diabetes Mellitus Review · M. Elizabeth Blair · 2016 · 304 citations · Cited by this paper
  29. Guidance on the planning and reporting of experimental design and analysis · Michael J. Curtis · 2025 · 258 citations · Cited by this paper
  30. The IUPHAR/BPS Guide to PHARMACOLOGY in 2024 · Simon D Harding · 2023 · 240 citations · Cited by this paper
  31. Sodium-Glucose Cotransporter 2 Inhibition and Glycemic Control in Type 1 Diabetes: Results of an 8-Week Open-Label Proof-of-Concept Trial · Bruce A. Perkins · 2014 · 232 citations · Cited by this paper
  32. SGLT2 Inhibition via Empagliflozin Improves Endothelial Function and Reduces Mitochondrial Oxidative Stress: Insights From Frail Hypertensive and Diabetic Patients · Pasquale Mone · 2022 · 222 citations · Cited by this paper
  33. Effects of Glucagon‐Like Peptide‐1 Receptor Agonists, Sodium‐Glucose Cotransporter‐2 Inhibitors, and Their Combination on Endothelial Glycocalyx, Arterial Function, and Myocardial Work Index in Patients With Type 2 Diabetes Mellitus After 12‐Month Treatment · Ignatios Ikonomidis · 2020 · 205 citations · Cited by this paper
  34. 2024 Update in Heart Failure · Alberto Beghini · 2024 · 200 citations · Cited by this paper
  35. A new class of drugs for heart failure: SGLT2 inhibitors reduce sympathetic overactivity · Motoaki Sano · 2018 · 194 citations · Cited by this paper
  36. Erythrocytes and Vascular Function: Oxygen and Nitric Oxide · Christine Carlisle Helms · 2018 · 168 citations · Cited by this paper
  37. Oxidative Stress in Healthy and Pathological Red Blood Cells · Florencia Orrico · 2023 · 165 citations · Cited by this paper
  38. Disorders of erythrocyte hydration · Patrick G. Gallagher · 2017 · 133 citations · Cited by this paper
  39. Effects of Sodium-Glucose Co-Transporter 2 Inhibitors on Vascular Cell Function and Arterial Remodeling · William Durante · 2021 · 130 citations · Cited by this paper

Source: OpenAlex (CC0)